Medicare billing address
CMS Medicare provider billing file
3830 Woodley Rd Ste BToledo, OH 43606
CMS public data · NPI 1609031509
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Saud A Alvi, M.D.,FACR
Specialty
Credential
M.D.,FACR
NPI
1609031509
Primary source state
OH
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Saud A Alvi, M.D.,FACR from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
3830 Woodley Rd Ste BCMS Doctors & Clinicians file
3830 Woodley RdCMS Doctors & Clinicians file
4235 Secor RdIn the 2024 CMS provider billing file, this NPI had 412 Medicare beneficiaries and 45,809 total services. The average beneficiary age was 73, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$1,003,678.35
Total Medicare payment amount
$783,826.46
Medicare beneficiaries
412
Total services
45,809
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
73%
CMS beneficiary-panel share
Hyperlipidemia
70%
CMS beneficiary-panel share
Osteoporosis
37%
CMS beneficiary-panel share
Diabetes
27%
CMS beneficiary-panel share
Chronic kidney disease
25%
CMS beneficiary-panel share
Mood disorders
23%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, golimumab, 1 mg, for intravenous use | 12,850 | $11.47 |
| Injection, denosumab, 1 mg | 5,640 | $24.40 |
| Injection, infliximab, excludes biosimilar, 10 mg | 5,170 | $31.44 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 916 | $119.28 |
| Injection, methylprednisolone sodium succinate, 5 mg | 650 | $0.29 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 262 | $6.60 |
| Administration of chemotherapy into vein, 1 hour or less | 249 | $116.67 |
| Insertion of needle into vein for collection of blood sample | 215 | $8.65 |
| Administration of chemotherapy into vein, each additional hour | 144 | $25.35 |
| Injection of drug or substance under skin or into muscle | 119 | $13.17 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1609031509. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Methotrexate | Methotrexate Sodium | 922 | 1,794.7 | $22,524.70 |
| 2 | Prednisone | Prednisone | 871 | 1,286.8 | $4,810.16 |
| 3 | Tizanidine Hcl | Tizanidine Hcl | 402 | 592.3 | $2,533.29 |
| 4 | Tramadol Hcl | Tramadol Hcl | 348 | 368 | $2,758.73 |
| 5 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 341 | 682 | $14,309.51 |
| 6 | Gabapentin | Gabapentin | 296 | 414 | $3,475.17 |
| 7 | Alendronate Sodium | Alendronate Sodium | 276 | 509.3 | $1,810.99 |
| 8 | Duloxetine Hcl | Duloxetine Hcl | 194 | 356 | $2,734.29 |
| 9 | Meloxicam | Meloxicam | 140 | 245.7 | $587.71 |
| 10 | Celecoxib | Celecoxib | 133 | 245 | $5,326.77 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1987
Group/practice field
Toledo Clinic Incorporated
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.